Transcranial doppler ultrasound assessment of intracranial hemodynamics in patients with type 2 diabetes mellitus

Annals of Saudi Medicine

Volumn 25, Issue 6, 2005, Pages 486-488

  Dikanovic, Marinko ^a   Hozo, Izet Salih ^b   Kokic, Slaven ^b   Titlic, Marina ^b   Jandric, Marica ^a   Balen, Ivan ^a   Kadojic, Dragutin ^c  

^a General Hospital Slavonski Brod   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

^c UNIVERSITY HOSPITAL OSIJEK   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; DOPPLER ECHOGRAPHY; FEMALE; FLOW RATE; GENDER; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 30944448116     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2005.486     Document Type: Article

References (20)

1. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults (The Cardiovascular Health Study Collaborative Research Group). N Engl J Med. 1999;340(1):14-22.
2. Mudrikova T. Szaboova E. Tkac I. Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wiener Klinische Wochenschrift. 2000;112(20):887-891.
3. Hunt KJ. Williams K. Rivera D. O'Leary DH. Haffner SM. Stern MP. Villalpando CG. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arteriosclerosis Thrombosis & Vascular Biology. 2003;23 (10):1845-1850.
4. Bonora E. Kiechl S. Oberhollenzer F. Egger G. Bonadonna RC. Muggeo M. Willeit J. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000;43(2):156-164.
5. Kokic S, Radman M, Capkun V, Kokic-Dovzak D, Tesanovic S. Comparative assessment of the treatment of type 2 diabetes mellitus. Annals of Saudi Medicine. 2002;22 (3-4):163-166.
6. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasoud recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769-74.
7. McCartney JP, Kathleen M, Lukas T, Gomez CR. Handbook of Transcranial Doppler. New York, Springer-Verlag 1997:1-85.
8. Krejza J, Mariak Z, Walecki J, Szydlik P, Lewko J, Ustymowicz A. Transcranial color Doppler sonography of basal cerebral arteries in 182 healthy subjects: age and sex variability and normal reference values for blood flow parameters. Am J Roentgenol. 1999;172:213-18
9. Alexandrov AV, Demarin V. Insonation techniques and diagnostic criteria for transcranial Doppler sonography. Acta Clin Croat. 1999;38:97-108
10. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia. 1995;38:1061-S.
11. Holt R. Targeting cardiovascular risk factors in patients with type 2 diabetes. Diabetes, Obesity & Metabolism. 2003; 5(4):269-73.
12. Wojczal J, Szerej AS, Belniak E, Blaszkowska A, Stelmasiak Z. The importance of transcranial Doppler (TCD) in the assessment of cerebrovascular hemodynamics of the acute phase of ischemic stroke. Neurol Neurochir Pol. 2003;37(1):185-93.
13. Lee KY, Sohn YH, Baik JS, Kim GW, Kim JS. Arterial pulsatility as an indeks of cerebral microangiopathy in diabetes. Stroke. 2000;31(5):1111-5.
14. Diehl RR, Samii C, Diehl A. Dynamics and embolic activity of symptomatic intra-cranial cerebral artery stenoses. Acta Neurol Scand. 2002;106(3):173-81.
15. Sprafka JM, Virnig BA, Shahar E, McGovern PG. Trends in diabetes prevalence among stroke patients and the effect of diabetes an stroke survival: the Minnesota Heart Survey. Diabet Med. 1994;11:678-84.
16. Bonora E. Kiechl S. Oberhollenzer F. Egger G. Bonadonna RC. Muggeo M. Willeit J. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000;43(2):156-164.
17. Haffner SM. D'Agostino R. Saad MF. O'Leary DH. Savage PJ. Rewers M. Selby J. Bergman RN. Mykkanen L. Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (the insulin resistance atherosclerosis study). American Journal of Cardiology. 2000;85(12):1395-1400.
18. Spijkerman AMW. Dekker JM. Nijpels G. Jager A. Kostense PJ. van Hinsbergh VWM. Bouter LM. Heine RJ. Stehouwer CDA. Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study. European Journal of Clinical Investigation. 2002;32(12):924-930.
19. O'Neal DN, Dragicevic G, Rowley KG, Ansari MZ, Balazs N, Jenkins A, Best JD. A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb. Diabetes Care. 2003;26(1):199-205.
20. Elmore EM, Mosequera A, Weinberger J. The prevalence of asymptomatic intracranial large-vessel occlusive disease: the role of diabetes. J Neuroimaging. 2003;13(3):224-7.